| Literature DB >> 20058202 |
Mariane Secco1, Yuri B Moreira, Eder Zucconi, Natassia M Vieira, Tatiana Jazedje, Alysson R Muotri, Oswaldo K Okamoto, Sergio Verjovski-Almeida, Mayana Zatz.
Abstract
Mesenchymal stem cells (MSC) are multipotent cells which can be obtained from several adult and fetal tissues including human umbilical cord units. We have recently shown that umbilical cord tissue (UC) is richer in MSC than umbilical cord blood (UCB) but their origin and characteristics in blood as compared to the cord remains unknown. Here we compared, for the first time, the exonic protein-coding and intronic noncoding RNA (ncRNA) expression profiles of MSC from match-paired UC and UCB samples, harvested from the same donors, processed simultaneously and under the same culture conditions. The patterns of intronic ncRNA expression in MSC from UC and UCB paired units were highly similar, indicative of their common donor origin. The respective exonic protein-coding transcript expression profiles, however, were significantly different. Hierarchical clustering based on protein-coding expression similarities grouped MSC according to their tissue location rather than original donor. Genes related to systems development, osteogenesis and immune system were expressed at higher levels in UCB, whereas genes related to cell adhesion, morphogenesis, secretion, angiogenesis and neurogenesis were more expressed in UC cells. These molecular differences verified in tissue-specific MSC gene expression may reflect functional activities influenced by distinct niches and should be considered when developing clinical protocols involving MSC from different sources. In addition, these findings reinforce our previous suggestion on the importance of banking the whole umbilical cord unit for research or future therapeutic use.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20058202 PMCID: PMC2803263 DOI: 10.1007/s12015-009-9098-5
Source DB: PubMed Journal: Stem Cell Rev Rep ISSN: 2629-3277 Impact factor: 5.739
Fig. 1Characterization of adherent cells isolated from UCB and UC. a, c Flow cytometric analysis of cell surface markers of MSC from UCB and UC, respectively. Representative histograms are demonstrated, and their respective controls are shown by the black lines. b, d Morphology of adherent cells isolated from UCB and UC. After 15 days in culture, all isolated MSC populations displayed a spindle-shaped morphology. e Differentiation potential of adherent cells isolated from UCB and UC. Osteogenic differentiation of adherent cells from UCB and UC was demonstrated by calcium deposition shown by von Kossa stain; Adipogenesis was detected by the formation of intracytoplasmic lipid droplets stained with oil red O; Cell spheres from UCB and UC were stained with toluidine blue to confirm chondrogenic differentiation. Mucopolysaccharide-rich extracellular matrix is shown in pinkish metachromatic areas. Abbreviations: CD cluster of differentiation; HLA-ABC human leukocyte antigen-ABC; HLA-DR human leukocyte antigen-DR; UCB umbilical cord blood; UC umbilical cord
Summary of surface markers expression in MSC from UCB and UC
| Surface Marker | UCB (%) | UC (%) |
|---|---|---|
| Control | 0.84 | 0.98 |
| CD 13 | 98.18 | 96.64 |
| CD 29 | 97.88 | 97.94 |
| CD 44 | 97.72 | 97.18 |
| CD73 | 98.26 | 98.84 |
| CD 34 | 1.46 | 3.26 |
| CD 45 | 1.10 | 4.54 |
| CD 117 | 1.88 | 1.38 |
| CD 31 | 1.22 | 1.28 |
| HLA-ABC | 93.10 | 99.82 |
| HLA-DR | 1.68 | 1.94 |
Data represent the mean of 3 different samples (n = 3). The results showed are percentage of positive cells
HLA-ABC human leukocyte antigen-ABC; HLA-DR human leukocyte antigen-DR; UC umbilical cord; UCB umbilical cord blood
Protein-coding and noncoding genes expressed in MSC from UC and UCB tissues
| Exonic | Intronic | All ncRNAs | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| probes | % | AS-TIN | S-TIN | AS-PIN | Other ncRNA | |||||||
| probes | % | probes | % | probes | % | probes | % | probes | % | |||
| On the Array | 13699 | 100 | 7515 | 100 | 7515 | 100 | 4920 | 100 | 662 | 100 | 20612 | 100 |
| Expressed in UC and UCB | 10935 | 80 | 1645 | 22 | 2420 | 32 | 2651 | 54 | 454 | 69 | 7170 | 35 |
| probes | %a | probes | %a | probes | %a | probes | %a | probes | %a | probes | %a | |
| Over-expressed in UC (FDR 5%) | 1054 | 10 | 30 | 2 | 68 | 3 | 118 | 5 | 18 | 4 | 234 | 3 |
| Over-expressed in UCB (FDR 5%) | 816 | 8 | 25 | 2 | 124 | 5 | 51 | 2 | 19 | 4 | 219 | 3 |
| Total differentially expressed | 1870 | 18 | 55 | 4 | 192 | 8 | 169 | 7 | 37 | 8 | 453 | 6 |
UCB umbilical cord blood; UC umbilical cord
aPercent over-expressed probes is calculated in relation to the total number of probes of this category that are expressed in UC and UCB
Fig. 2Non-supervised hierarchical clustering of a all 10,935 protein-coding genes and b all 7,170 intronic noncoding RNAs, expressed in MSC from UC and UCB. Each row represents the relative levels of expression for a single gene, calculated as the number of standard deviations above (red) or below (green) the mean expression level of that gene across the samples. Each column represents the average expression of two technical replicate (Cy3 and Cy5) measurements of each sample. In a MSC isolated from the same tissue clustered together while MSC from different tissues (UC or UCB) and same donors are found in different clusters. In b MSC isolated from different tissues (UC or UCB) and the same donor clustered together while MSC from the same tissue and different donors are found in different clusters
Correlation coefficients (r2) among expression profiles
| r2 within same tissue | UC vs UCB |
| ||
|---|---|---|---|---|
| r2 within same donor | ||||
| A) Protein-coding gene expression: analysis of correlations between MSC from UC and UCB | ||||
| UC | 0.94 ± 0.025 | 0.89 ± 0.041 | 0.026 | |
| UCB | 0.92 ± 0.019 | 0.89 ± 0.041 | 0.067 | |
| B) Noncoding gene expression: analysis of correlations between MSC from UC and UCB | ||||
| UC | 0.98 ± 0.005 | 0.99 ± 0.006 | 0.060 | |
| UCB | 0.98 ± 0.007 | 0.99 ± 0.006 | 0.029 | |
Data shown are mean ± SD from r2 values within each group (r2 data from Figure S5)
UCB umbilical cord blood; UC umbilical cord
Fig. 3Expression signature of protein-coding transcripts in MSC from UC and UCB. A total of 1,870 genes with significantly different levels among MSC from UC and UCB samples were identified by SAM one-class statistical analysis (FDR < 5%) and hierarchically clustered as described in Materials and Methods. Each row represents the relative levels of expression for a single gene, calculated as the number of standard deviations above (red) or below (green) the average expression level of that gene across the samples. Each column represents the average expression of two technical replicate (Cy3 and Cy5) measurements of each sample
Top 30 over-expressed protein-coding genes in MSC from UC
| Overexpressed in UC | |||||
|---|---|---|---|---|---|
| Entrez Gene ID | Gene Symbol | Mapping.location | Description | SAM q-value (%) | Fold Change |
| 139065 | SLITRK4 | Xq27.3 | SLIT and NTRK-like family, member 4 | 0 | 126.1 |
| 590 | BCHE | 3q26.1-q26.2 | butyrylcholinesterase | 0 | 88.4 |
| 10580 | SORBS1 | 10q23.3-q24.1 | sorbin and SH3 domain containing 1 | 0 | 57.8 |
| 10788 | IQGAP2 | 5q13.3 | IQ motif containing GTPase activating protein 2 | 0 | 53.4 |
| 2321 | FLT1 | 13q12 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0 | 52.7 |
| 9699 | RIMS2 | 8q22.3 | regulating synaptic membrane exocytosis 2 | 0 | 27.2 |
| 7980 | TFPI2 | 7q22 | tissue factor pathway inhibitor 2 | 0 | 25.7 |
| 25849 | DKFZP564O0823 | 4q13.3-q21.3 | DKFZP564O0823 protein | 0 | 25.4 |
| 753 | C18orf1 | 18p11.2 | chromosome 18 open reading frame 1 | 0 | 23.8 |
| 171024 | SYNPO2 | 4q26 | synaptopodin 2 | 0 | 21.1 |
| 57110 | HRASLS | 3q29 | HRAS-like suppressor | 0 | 19.9 |
| 144100 | PLEKHA7 | 11p15.1 | pleckstrin homology domain containing, family A member 7 | 0 | 19.0 |
| 244 | ANXA8 | 10q11.2 | annexin A8 | 0 | 17.4 |
| 1803 | DPP4 | 2q24.3 | dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) | 0 | 16.8 |
| 55691 | FRMD4A | 10p13 | FERM domain containing 4A | 0 | 16.1 |
| 121551 | BTBD11 | 12q23.3 | BTB (POZ) domain containing 11 | 0 | 16.1 |
| 50507 | NOX4 | 11q14.2-q21 | NADPH oxidase 4 | 0 | 15.1 |
| 6653 | SORL1 | 11q23.2-q24.2 | sortilin-related receptor, L(DLR class) A repeats-containing | 0 | 14.9 |
| 158038 | LRRN6C | 9p21.2-p21.1 | leucine rich repeat neuronal 6C | 0 | 14.7 |
| 22998 | DKFZP686A01247 | 4p13 | hypothetical protein | 0 | 11.3 |
| 104 | ADARB1 | 21q22.3 | adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) | 0 | 11.2 |
| 7163 | TPD52 | 8q21 | tumor protein D52 | 0 | 11.0 |
| 23555 | TSPAN15 | 10q21.3 | tetraspanin 15 | 0 | 10.7 |
| 55022 | FLJ20701 | 2q36.3 | hypothetical protein FLJ20701 | 0 | 9.4 |
| 8828 | NRP2 | 2q33.3 | neuropilin 2 | 0 | 9.3 |
| 54361 | WNT4 | 1p36.23-p35.1 | wingless-type MMTV integration site family, member 4 | 0 | 9.3 |
| 256435 | ST6GALNAC3 | 1p31.1 | 1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | 0 | 9.3 |
| 5924 | RASGRF2 | 5q13 | Ras protein-specific guanine nucleotide-releasing factor 2 | 0 | 9.1 |
Top 30 over-expressed protein-coding genes in MSC from UCB
| Overexpressed in UC | |||||
|---|---|---|---|---|---|
| Entrez Gene ID | Gene Symbol | Mapping.location | Description | SAM q-value (%) | Fold Change |
| 84302 | C9orf125 | 9q31.1 | chromosome 9 open reading frame 125 | 0 | 51.5 |
| 81578 | COL21A1 | 6p12.3-p11.2 | collagen, type XXI, alpha 1 | 0 | 40.0 |
| 3679 | ITGA7 | 12q13 | integrin, alpha 7 | 0 | 28.1 |
| 79614 | C5orf23 | 5p13.3 | chromosome 5 open reading frame 23 | 0 | 25.7 |
| 2044 | EPHA5 | 4q13.1 | EPH receptor A5 | 0 | 25.0 |
| 2006 | ELN | 7q11.23 | elastin (supravalvular aortic stenosis, Williams-Beuren syndrome) | 0 | 23.9 |
| 7373 | COL14A1 | 8q23 | collagen, type XIV, alpha 1 (undulin) | 0 | 23.9 |
| 10631 | POSTN | 13q13.3 | periostin, osteoblast specific factor | 0 | 22.3 |
| 5168 | ENPP2 | 8q24.1 | ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin) | 0 | 16.7 |
| 5137 | PDE1C | 7p15.1-p14.3 | phosphodiesterase 1C, calmodulin-dependent 70kDa | 0 | 15.3 |
| 8839 | WISP2 | 20q12-q13.1 | WNT1 inducible signaling pathway protein 2 | 0 | 15.2 |
| 183 | AGT | 1q42-q43 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0 | 14.4 |
| 8490 | RGS5 | 1q23.1 | regulator of G-protein signalling 5 | 0 | 13.9 |
| 182 | JAG1 | 20p12.1-p11.23 | jagged 1 (Alagille syndrome) | 0 | 13.1 |
| 1879 | EBF1 | 5q34 | early B-cell factor 1 | 0 | 12.5 |
| 253738 | EBF3 | 10q26.3 | early B-cell factor 3 | 0 | 12.3 |
| 2012 | EMP1 | 12p12.3 | epithelial membrane protein 1 | 0 | 11.7 |
| 6696 | SPP1 | 4q21-q25 | secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) | 0 | 10.9 |
| 23136 | EPB41L3 | 18p11.32 | erythrocyte membrane protein band 4.1-like 3 | 0 | 10.7 |
| 3983 | ABLIM1 | 10q25 | actin binding LIM protein 1 | 0 | 10.5 |
| 3783 | KCNN4 | 19q13.2 | potassium intermediate/small conductance calciumactivated channel, subfamily N, member 4 | 0 | 10.2 |
| 342184 | FMN1 | 15q13.3 | formin 1 | 0 | 10.1 |
| 5328 | PLAU | 10q24 | plasminogen activator, urokinase | 0 | 9.2 |
| 130916 | MTERFD2 | 2q37.3 | MTERF domain containing 2 | 0 | 8.6 |
| 9510 | ADAMTS1 | 21q21.2 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0 | 8.5 |
| 9783 | RIMS3 | 1pter-p22.2 | regulating synaptic membrane exocytosis 3 | 0 | 7.9 |
| 57520 | HECW2 | 2q32.3-q33.1 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 | 0 | 7.9 |
| 4629 | MYH11 | 16p13.11 | myosin, heavy chain 11, smooth muscle | 0 | 7.8 |
| 255488 | IBRDC2 | 6p22.3 | IBR domain containing 2 | 0 | 6.8 |